← Leaderboards
Narine Sarvazyan
Texas Tech University Health Scis Center
$5,866,904
Attributed
$8,030,614
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,030,614 · 6
By mechanism
R44$2,995,944 · 1
R42$2,273,404 · 1
R01$2,129,302 · 2
R21$431,963 · 1
R41$200,001 · 1
Top collaborators
- Omar Amirana3 shared
- Terry Ransbury3 shared
- Matthew W. Kay2 shared
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesArrhythmiaSourceHeartCardiac MyocytesFamily SuidaeDesignCardiacImageMonitorMorbidity - Disease RateCathetersAtrial FibrillationChestHeart AtriumProceduresInjuryAnimalsBaseCardiac AblationLesionCollagenDevicesAblation
Grant awards (17)
New generation of catheters for treatment of atrial fibrillation$998,310
R44 · FY2025 · HL
New generation of catheters for treatment of atrial fibrillation$998,658
R44 · FY2024 · HL
New generation of catheters for treatment of atrial fibrillation$998,976
R44 · FY2023 · HL
New generation of catheters for treatment of atrial fibrillation$1,100,322
R42 · FY2017 · HL · contact PI
New generation of catheters for treatment of atrial fibrillation$1,173,082
R42 · FY2016 · HL · contact PI
Cardiomyocyte-derived Venous Assist Device: Aiding peripheral blood flow$198,125
R21 · FY2016 · HL · contact PI
Cardiomyocyte-derived Venous Assist Device: Aiding peripheral blood flow$233,838
R21 · FY2015 · HL · contact PI
New generation of catheters for treatment of atrial fibrillation$200,001
R41 · FY2014 · HL · contact PI
Non-reentrant arrhythmias: ectopic nexus hypothesis$362,679
R01 · FY2007 · HL · contact PI
Non-reentrant arrhythmias: ectopic nexus hypothesis$373,511
R01 · FY2006 · HL · contact PI
Non-reentrant arrhythmias: ectopic nexus hypothesis$459,000
R01 · FY2005 · HL
Non-reentrant arrhythmias: ectopic nexus hypothesis$321,999
R01 · FY2004 · HL
Non-reentrant arrhythmias: ectopic nexus hypothesis$76,500
R01 · FY2004 · HL
Non-reentrant arrhythmias: ectopic nexus hypothesis$36,175
R01 · FY2004 · HL
ANTHRACYCLINE CARDIOTOXICITY--OXIDATIVE STRESS$171,423
R01 · FY2002 · HL
ANTHRACYCLINE CARDIOTOXICITY--OXIDATIVE STRESS$166,432
R01 · FY2001 · HL
ANTHRACYCLINE CARDIOTOXICITY--OXIDATIVE STRESS$161,583
R01 · FY2000 · HL